Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis, Inc. - Common Stock (NQ: EXEL ) 34.00 +0.18 (+0.53%) Streaming Delayed Price Updated: 3:15 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 643,669 Open 33.72 Bid (Size) 33.97 (19) Ask (Size) 34.00 (6) Prev. Close 33.82 Today's Range 33.71 - 34.09 52wk Range 19.20 - 36.97 Shares Outstanding 315,048,788 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Investors should take notice of NASDAQ:EXEL—it offers a great deal for the fundamentals it presents. December 20, 2024 EXELIXIS INC (NASDAQ:EXEL) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. Via Chartmill Peering Into Exelixis's Recent Short Interest December 18, 2024 Via Benzinga Performance YTD +42.08% +42.08% 1 Month -6.54% -6.54% 3 Month +30.47% +30.47% 6 Month +51.92% +51.92% 1 Year +41.55% +41.55% More News Read More Expert Outlook: Exelixis Through The Eyes Of 19 Analysts December 17, 2024 Via Benzinga This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday December 17, 2024 Via Benzinga NASDAQ:EXEL is showing decent growth, but is still valued reasonably. December 16, 2024 Via Chartmill Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report December 13, 2024 Via Benzinga Earnings Preview: Exelixis October 28, 2024 Via Benzinga 1 No-Brainer Stock to Buy With $40 October 23, 2024 Via The Motley Fool 2 Biotech Stocks to Buy Hand Over Fist in December December 07, 2024 Via The Motley Fool End Of Year Rally: 3 Stocks To Watch (InterDigital, Futu Holdings, Exelixis) December 01, 2024 Via Talk Markets Topics Stocks / Equities Ten Young Ones November 30, 2024 Via Talk Markets Topics Stocks / Equities NASDAQ:EXEL appears to be flying under the radar despite its strong fundamentals. November 29, 2024 Via Chartmill Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December November 27, 2024 From Exelixis, Inc. Via Business Wire Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib (CABOMETYX®) for the Treatment of Patients with Previously Treated Advanced Neuroendocrine Tumors November 26, 2024 From Exelixis, Inc. Via Business Wire BioNTech Stock Got A IBD RS Rating Lift November 14, 2024 Via Investor's Business Daily Vericel Stock Sees RS Rating Shoot Higher November 11, 2024 Via Investor's Business Daily NASDAQ:EXEL is an undervalued gem with solid fundamentals. November 08, 2024 Via Chartmill Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November November 07, 2024 From Exelixis, Inc. Via Business Wire 3 Magnificent Stocks Under $100 to Buy in November November 03, 2024 Via The Motley Fool Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? November 03, 2024 Via Benzinga Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday October 30, 2024 Via Benzinga Exelixis (EXEL) Q3 2024 Earnings Call Transcript October 30, 2024 Via The Motley Fool Topics Earnings Exposures Financial Exelixis Announces Third Quarter 2024 Financial Results and Provides Corporate Update October 29, 2024 From Exelixis, Inc. Via Business Wire Biotech Momentum Trades For The Q4 Rally October 29, 2024 Via Talk Markets Momentum Has Narrowed Again, Significantly October 28, 2024 Via Talk Markets Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
